416 related articles for article (PubMed ID: 31145756)
1. CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo.
Chatterjee B; Deng Y; Holler A; Nunez N; Azzi T; Vanoaica LD; Müller A; Zdimerova H; Antsiferova O; Zbinden A; Capaul R; Dreyer JH; Nadal D; Becher B; Robinson MD; Stauss H; Münz C
PLoS Pathog; 2019 May; 15(5):e1007748. PubMed ID: 31145756
[TBL] [Abstract][Full Text] [Related]
2. Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases.
Abbott RJ; Pachnio A; Pedroza-Pacheco I; Leese AM; Begum J; Long HM; Croom-Carter D; Stacey A; Moss PAH; Hislop AD; Borrow P; Rickinson AB; Bell AI
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835490
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control
Murer A; Rühl J; Zbinden A; Capaul R; Hammerschmidt W; Chijioke O; Münz C
mBio; 2019 Jan; 10(1):. PubMed ID: 30647153
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired.
Cárdenas D; Vélez G; Orfao A; Herrera MV; Solano J; Olaya M; Uribe AM; Saavedra C; Duarte M; Rodríguez M; López M; Fiorentino S; Quijano S
Clin Exp Immunol; 2015 Nov; 182(2):173-83. PubMed ID: 26174440
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.
Albanese M; Tagawa T; Bouvet M; Maliqi L; Lutter D; Hoser J; Hastreiter M; Hayes M; Sugden B; Martin L; Moosmann A; Hammerschmidt W
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6467-E6475. PubMed ID: 27698133
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
Serafini B; Rosicarelli B; Veroni C; Mazzola GA; Aloisi F
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578295
[TBL] [Abstract][Full Text] [Related]
7. Exhausted cytotoxic control of Epstein-Barr virus in human lupus.
Larsen M; Sauce D; Deback C; Arnaud L; Mathian A; Miyara M; Boutolleau D; Parizot C; Dorgham K; Papagno L; Appay V; Amoura Z; Gorochov G
PLoS Pathog; 2011 Oct; 7(10):e1002328. PubMed ID: 22028659
[TBL] [Abstract][Full Text] [Related]
8. Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15.
Zdimerova H; Murer A; Engelmann C; Raykova A; Deng Y; Gujer C; Rühl J; McHugh D; Caduff N; Naghavian R; Pezzino G; Capaul R; Zbinden A; Ferlazzo G; Lünemann JD; Martin R; Chatterjee B; Münz C
Eur J Immunol; 2021 Jan; 51(1):64-75. PubMed ID: 32949466
[TBL] [Abstract][Full Text] [Related]
9. Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Morishima S; Nakamura S; Yamamoto K; Miyauchi H; Kagami Y; Kinoshita T; Onoda H; Yatabe Y; Ito M; Miyamura K; Nagai H; Moritani S; Sugiura I; Tsushita K; Mihara H; Ohbayashi K; Iba S; Emi N; Okamoto M; Iwata S; Kimura H; Kuzushima K; Morishima Y
Leuk Lymphoma; 2015 Apr; 56(4):1072-8. PubMed ID: 24975317
[TBL] [Abstract][Full Text] [Related]
10. Role of the 2B4 Receptor in CD8+ T-Cell-Dependent Immune Control of Epstein-Barr Virus Infection in Mice With Reconstituted Human Immune System Components.
Chijioke O; Marcenaro E; Moretta A; Capaul R; Münz C
J Infect Dis; 2015 Sep; 212(5):803-7. PubMed ID: 25722295
[TBL] [Abstract][Full Text] [Related]
11. Sepsis erodes CD8
Xie J; Crepeau RL; Chen CW; Zhang W; Otani S; Coopersmith CM; Ford ML
J Leukoc Biol; 2019 Mar; 105(3):565-575. PubMed ID: 30624806
[TBL] [Abstract][Full Text] [Related]
12. Severity of Acute Infectious Mononucleosis Correlates with Cross-Reactive Influenza CD8 T-Cell Receptor Repertoires.
Aslan N; Watkin LB; Gil A; Mishra R; Clark FG; Welsh RM; Ghersi D; Luzuriaga K; Selin LK
mBio; 2017 Dec; 8(6):. PubMed ID: 29208744
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
Ressing ME; Horst D; Griffin BD; Tellam J; Zuo J; Khanna R; Rowe M; Wiertz EJ
Semin Cancer Biol; 2008 Dec; 18(6):397-408. PubMed ID: 18977445
[TBL] [Abstract][Full Text] [Related]
14. [An analysis of immunophenotyping of peripheral lymphocytes in adult patients with infectious mononucleosis and chronic active Epstein-Barr virus infection].
Xie J; Wang HL; Qiu ZF; Li TS
Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):455-9. PubMed ID: 27256608
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of PD-1 expression on CD8 T cells in patients post-renal transplant irrespective of chronic high EBV viral load.
Moran J; Dean J; De Oliveira A; O'Connell M; Riordan M; Connell J; Awan A; Hall WW; Hassan J
Pediatr Transplant; 2013 Dec; 17(8):806-14. PubMed ID: 24118875
[TBL] [Abstract][Full Text] [Related]
16. Programmed Death-1 expression on Epstein Barr virus specific CD8+ T cells varies by stage of infection, epitope specificity, and T-cell receptor usage.
Greenough TC; Campellone SC; Brody R; Jain S; Sanchez-Merino V; Somasundaran M; Luzuriaga K
PLoS One; 2010 Sep; 5(9):e12926. PubMed ID: 20886079
[TBL] [Abstract][Full Text] [Related]
17. Dynamic CD8 T-cell responses to tumor-associated Epstein-Barr virus antigens in patients with Epstein-Barr virus-negative Hodgkin's disease.
Kohrt H; Johannsen A; Hoppe R; Horning SJ; Rosenberg SA; Advani R; Lee PP
Oncol Res; 2009; 18(5-6):287-92. PubMed ID: 20225766
[TBL] [Abstract][Full Text] [Related]
18. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus.
Kang I; Quan T; Nolasco H; Park SH; Hong MS; Crouch J; Pamer EG; Howe JG; Craft J
J Immunol; 2004 Jan; 172(2):1287-94. PubMed ID: 14707107
[TBL] [Abstract][Full Text] [Related]
19. The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.
Sugita Y; Furuta T; Ohshima K; Komaki S; Miyoshi J; Morioka M; Abe H; Nozawa T; Fujii Y; Takahashi H; Kakita A
Neuropathology; 2018 Apr; 38(2):125-134. PubMed ID: 29067721
[TBL] [Abstract][Full Text] [Related]
20. Spatiotemporally Skewed Activation of Programmed Cell Death Receptor 1-Positive T Cells after Epstein-Barr Virus Infection and Tumor Development in Long-Term Fully Humanized Mice.
Danisch S; Slabik C; Cornelius A; Albanese M; Tagawa T; Chen YA; Krönke N; Eiz-Vesper B; Lienenklaus S; Bleich A; Theobald SJ; Schneider A; Ganser A; von Kaisenberg C; Zeidler R; Hammerschmidt W; Feuerhake F; Stripecke R
Am J Pathol; 2019 Mar; 189(3):521-539. PubMed ID: 30593822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
